中草药

外泌体纯化和药物递送系统的工艺优化：提升人参皂苷Rg₁跨血脑屏障效率的天然载体

PDF下载

中草药 | 药剂与工艺 2026,57(12): 4570-4581

收起

中草药 |药剂与工艺 2026 , 57 (12) : 4570 -4581

外泌体纯化和药物递送系统的工艺优化：提升人参皂苷Rg₁跨血脑屏障效率的天然载体

全屏

李梦茹¹, 张明世¹, 尹秋燕¹, 张德赟¹, 叶彤¹, 石艳雪¹, 闫滨¹, 白天凯²

作者信息

通讯作者:

闫滨

作者简介:

李梦茹: 李梦茹，女，硕士研究生，研究方向为中药化学。E-mail:abbbbbh2025@163.com

Process optimization of exosome purification and process optimization of drug delivery systems: Natural carriers to enhance blood brain barrier penetration efficiency of ginsenoside Rg₁

LI Mengru, ZHANG Mingshi, YIN Qiuyan, ZHANG Deyun, YE Tong, SHI Yanxue, YAN Bin, BAI Tiankai

Affiliations

doi: 10.7501/j.issn.0253-2670.2026.12.006

文章导航

摘要

收起

目的筛选外泌体最佳纯化与载药工艺，构建体外血脑屏障（blood brain barrier，BBB）细胞模型和阿尔茨海默病小鼠（Alzheimer’s disease，AD）模型，探究人胚肾293亚系（human embryonic kidney 293T，HEK 293T）细胞外泌体（exosome，Exo）介导人参皂苷Rg₁（ginsenoside Rg₁，Rg₁）跨BBB效率，为脑部疾病治疗提供依据。方法分别采用超速离心法、切向流法、双耦合谐波振荡技术纯化外泌体，以浓度、粒径及多分散性指数（polydispersity index，PDI）为评价指标，选取最佳纯化方法；在电转电压、脉冲时间、脉冲次数、Rg₁质量浓度单因素筛选的基础上，以药物包封率为评价指标，利用正交设计优化电穿孔法构建Exo-Rg₁复合物的工艺；采用小鼠微脑血管内皮细胞（brain endothelial cell line 3，bEnd.3）构建体外BBB模型，通过测定跨内皮电阻（transendothelial electrical resistance，TEER）、液面渗透及荧光素钠渗透实验验证模型完整性；设置Exo-Rg₁复合物组（实验组）、游离Rg₁组（对照组）、单外泌体组和外泌体（空载）＋游离Rg₁组，采用HPLC检测不同时间点药物透过体外BBB细胞模型的浓度，计算透过效率。通过AD模型小鼠的行为学实验、组织学观察、蛋白与炎症因子检测，评估体内治疗效果。结果最佳纯化外泌体工艺为双耦合谐波振荡技术，所得外泌体浓度为2.9×10¹¹个/mL，粒径集中在（91.8±1.5）nm，PDI为0.21±0.01；优化后的最佳电穿孔法电转工艺为电转电压100 V、脉冲时间15 ms、脉冲次数5次和Rg₁质量浓度为0.4 mg/mL，此条件下复合物包封率为61.58%，优于传统的超声法；成功构建bEnd.3细胞体外BBB模型，TEER值稳定在300 Ω·cm²以上，并且4 h后体外BBB模型组仍能保持明显的液面差，模型组荧光素钠透过率显著小于空白对照组［（41.34±1.83）% vs（98.87±2.09）%，P＜0.01］，符合屏障功能要求；体外透过实验显示，8 h实验组Rg₁透过效率（15.3%）显著高于对照组（3.3%）（P＜0.05）；动物实验显示，复合物可显著改善模型小鼠学习记忆能力，保护海马神经元，上调胆碱乙酰转移酶（choline acetyltransferase，ChAT）及α7烟碱型乙酰胆碱受体（α7 nicotinic acetylcholine receptor，α7 nAChR）相关蛋白表达，降低白细胞介素-1β（interleukin-1β，IL-1β）、IL-6和肿瘤坏死因子-α（tumor necrosis factor-α，TNF-α）炎症因子水平，且效果优于游离Rg₁组与单外泌体组。结论外泌体可有效提升Rg₁跨越BBB的效率，为改善脑部疾病治疗效果提供实验依据。

关键词

外泌体 / 人参皂苷Rg₁ / 血脑屏障 / 药物递送系统 / bEnd.3细胞 / 双耦合谐波振荡技术 / 胆碱乙酰转移酶 / α7烟碱型乙酰胆碱受体 / 白细胞介素-1β / 肿瘤坏死因子-α

Abstract

收起

Objective To screen the optimal purification and drug-loading processes of exosomes (Exo), construct an in vitro blood-brain barrier (BBB) cell model and an Alzheimer’s disease (AD) mouse model, and investigate the efficiency of human embryonic kidney 293T (HEK 293T) Exo-mediated ginsenoside Rg₁ (Rg₁) across the BBB, so as to provide a basis for the treatment of brain diseases. Methods Exosomes were purified using ultracentrifugation, tangential flow filtration, and dual-coupled harmonic oscillation technology. The optimal purification method was selected based on concentration, particle size, and polydispersity index (PDI). On the basis of single-factor screening of voltage, pulse duration, pulse number, and Rg₁ concentration, the electroporation process for constructing Exo-Rg₁ complexes was optimized using orthogonal design with drug encapsulation efficiency as the evaluation index. An in vitro BBB model was established using brain endothelial cell line 3 (bEnd.3). Model integrity was verified by measuring transendothelial electrical resistance (TEER), liquid level permeability, and sodium fluorescein permeability. The Exo-Rg₁ complex group (experimental group), free Rg₁ group (control group), exosome alone group, and empty exosome + free Rg₁ group were set up. The concentration of Rg₁ penetrating the in vitro BBB model at different time points was detected by HPLC, and the permeability efficiency was calculated. In vivo therapeutic effects were evaluated through behavioral tests, histological observation, and detection of protein and inflammatory factor levels in AD model mice. Results The optimal exosome purification process was dual-coupled harmonic oscillation technology, yielding an exosome concentration of 2.9 × 10¹¹ particles/mL, a particle size of (91.8 ± 1.5) nm, and a PDI of 0.21 ± 0.01. The optimized electroporation conditions were voltage of 100 V, pulse duration of 15 ms, pulse number of four times, and Rg₁ concentration of 0.4 mg/mL. Under these conditions, the encapsulation efficiency of the complexes was 61.58%, which was superior to that of the traditional ultrasonic method. The in vitro BBB model using bEnd.3 cells was successfully established, with TEER values stably above 300 Ω·cm². A significant liquid level difference was maintained in the in vitro BBB model group after 4 h. The sodium fluorescein permeability in the model group was significantly lower than that in the blank control group [(41.34 ± 1.83)% vs (98.87 ± 2.09)%, P < 0.01], meeting the requirements for barrier function. In vitro penetration experiments showed that the penetration efficiency of Rg₁ in the experimental group (15.3%) was significantly higher than that in the control group (3.3%) at 8 h (P < 0.05). Animal experiments demonstrated that the complex significantly improved learning and memory abilities in model mice, protected hippocampal neurons, upregulated the expression of choline acetyltransferase (ChAT) and α7 nicotinic acetylcholine receptor (α7 nAChR) proteins, and reduced the levels of interleukin-1β (IL-1β), IL-6, and tumor necrosis factor-α (TNF-α), with effects superior to those of the free Rg₁ group and the exosome-only group. Conclusion Exosomes can effectively enhance the efficiency of Rg₁ in crossing the BBB, providing an experimental basis for improving the therapeutic effect of brain diseases.

Key words

exosome / ginsenoside Rg₁ / blood-brain barrier / drug delivery systems / bEnd.3 cells / dual-coupled harmonic oscillation technology / choline acetyltransferase / alpha-7 nicotinic acetylcholine receptor / interleukin-1β / tumor necrosis factor-α

引用本文

李梦茹, 张明世, 尹秋燕, 张德赟, 叶彤, 石艳雪, 闫滨, 白天凯. 外泌体纯化和药物递送系统的工艺优化：提升人参皂苷Rg₁跨血脑屏障效率的天然载体. 中草药, 2026 , 57 (12) : 4570 -4581 . DOI: 10.7501/j.issn.0253-2670.2026.12.006

LI Mengru, ZHANG Mingshi, YIN Qiuyan, ZHANG Deyun, YE Tong, SHI Yanxue, YAN Bin, BAI Tiankai. Process optimization of exosome purification and process optimization of drug delivery systems: Natural carriers to enhance blood brain barrier penetration efficiency of ginsenoside Rg₁[J]. Chinese Traditional and Herbal Drugs, 2026 , 57 (12) : 4570 -4581 . DOI: 10.7501/j.issn.0253-2670.2026.12.006

基金

收起

国家自然科学基金资助项目 (82374311)

参考文献

收起

文献

收起

参考文献引证文献

排序方式：

Ballabh P, Braun A, Nedergaard M. The blood-brain barrier: An overview structure, regulation, and clinical implications [J]. Neurobiol Dis, 2004, 16(1): 1-13.
Zhao Y H, Liu N W, Ke C C, et al. Combined treatment of sodium ferulate, n-butylidenephthalide, and ADSCs rehabilitates neurovascular unit in rats after photothrombotic stroke [J]. J Cell Mol Med, 2019, 23(1): 126-142.
王维刚, 林瑶, 巨佳, 等. 人参皂苷神经保护作用研究进展[J]. 解放军药学学报, 2024, 37(6): 591-600.
杨岩涛, 赵佳柱, 肖佳妹, 等. 人参皂苷治疗阿尔茨海默病的药理作用研究进展[J]. 中国药理学通报, 2021, 37(12): 1638-1643.
Yang S J, Wang J J, Cheng P, et al. Ginsenoside Rg₁ in neurological diseases: From bench to bedside [J]. Acta Pharmacol Sin, 2023, 44(5): 913-930.
Wei W L, Li Z W, Li H, et al. Exploration of tissue distribution of ginsenoside Rg₁ by LC-MS/MS and nanospray desorption electrospray ionization mass spectrometry [J]. J Pharm Biomed Anal, 2021, 198: 113999.
Lai J J, Chau Z L, Chen S Y, et al. Exosome processing and characterization approaches for research and technology development [J]. Adv Sci, 2022, 9(15): 2103222.
Doyle L M, Wang M Z. Overview of extracellular vesicles, their origin, composition, purpose, and methods for exosome isolation and analysis [J]. Cells, 2019, 8(7): 727.
Kibria G, Ramos E K, Wan Y, et al. Exosomes as a drug delivery system in cancer therapy: Potential and challenges [J]. Mol Pharmaceutics, 2018, 15(9): 3625-3633.
卓岩. 基于膜融合策略的工程化牛奶外泌体设计及其用于siRNA高效递送的研究[D]. 南昌: 南昌大学, 2024.
Shao J T, Zaro J, Shen Y X. Advances in exosome-based drug delivery and tumor targeting: From tissue distribution to intracellular fate [J]. Int J Nanomed, 2020, 15: 9355-9371.
Kim T, Hong J W, Lee L P. Efficient methods of isolation and purification of extracellular vesicles [J]. Nano Convergence, 2025, 12(1): 45.
Chen Y C, Zhu Q F, Cheng L M, et al. Exosome detection via the ultrafast-isolation system: Exodus [J]. Nat Meth, 2021, 18(2): 212-218.
Auquière M, Muccioli G G, des Rieux A. Methods and challenges in purifying drug-loaded extracellular vesicles [J]. J Extracell Vesicles, 2025, 14(6): e70097.
闫洁, 常恬, 章竟, 等. 用于炎症治疗的磷脂酰丝氨酸修饰胞外囊泡纳米递药系统的初步构建与评价[J]. 江苏大学学报: 医学版, 2024, 34(1): 79-84.
Shen J N, Ma Z T, Xu J Q, et al. Exosome isolation and detection: From microfluidic chips to nanoplasmonic biosensor [J]. ACS Appl Mater Interfaces, 2024, 16(18): 22776-22793.
Yang D B, Zhang W H, Zhang H Y, et al. Progress, opportunity, and perspective on exosome isolation-efforts for efficient exosome-based theranostics [J]. Theranostics, 2020, 10(8): 3684-3707.
Chen P, Ruan A M, Zhou J, et al. Extraction and identification of synovial tissue-derived exosomes by different separation techniques [J]. J Orthop Surg Res, 2020, 15(1): 97.
Ahmed R, Sayegh N, Graciotti M, et al. Electroporation as a method of choice to generate genetically modified dendritic cell cancer vaccines [J]. Curr Opin Biotechnol, 2020, 65: 142-155.
Kamerkar S, LeBleu V S, Sugimoto H, et al. Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer [J]. Nature, 2017, 546(7659): 498-503.
高舒颖, 梁爽, 刘永军, 等. 外泌体在基因递送系统中的研究进展[J]. 中国医药工业杂志, 2023, 54(3): 295-303.
赵燕, 王强, 王萃, 等. 舒芬太尼调节GAS6/Axl信号通路对高血压性脑出血大鼠血脑屏障和神经损伤的影响[J]. 免疫学杂志, 2024, 40(7): 581-586.
Morofuji Y, Nakagawa S. Drug development for central nervous system diseases using in vitro blood-brain barrier models and drug repositioning [J]. Curr Pharm Des, 2020, 26(13): 1466-1485.
Abbott N J, Patabendige A A K, Dolman D E M, et al. Structure and function of the blood-brain barrier [J]. Neurobiol Dis, 2010, 37(1): 13-25.
王伯松, 郭安臣, 王群. 体外血脑屏障模型的研究进展及其在新药研发中的作用[J]. 中国医药指南, 2019, 17(14): 54-58.
Paba C, Dorigo V, Senigagliesi B, et al. Lipid bilayer fluidity and degree of order regulates small EVs adsorption on model cell membrane [J]. J Colloid Interface Sci, 2023, 652(Pt B): 1937-1943.
Midekessa G, Godakumara K, Ord J, et al. Zeta potential of extracellular vesicles: Toward understanding the attributes that determine colloidal stability [J]. ACS Omega, 2020, 5(27): 16701-16710.
Sakai-Kato K, Hidaka M, Un K, et al. Physicochemical properties and in vitro intestinal permeability properties and intestinal cell toxicity of silica particles, performed in simulated gastrointestinal fluids [J]. Biochim Biophys Acta BBA Gen Subj, 2014, 1840(3): 1171-1180.

2026年第57卷第12期

PDF下载

引用本文

BibTeX

文章信息

doi: 10.7501/j.issn.0253-2670.2026.12.006

接收时间：2026-01-23
首发时间：2026-09-09

补充材料

相关文章

文章信息

作者

出版历史

收稿日期：2026-01-23

基金

作者信息

参考文献

分享链接

https://castjournals.cast.org.cn/joweb/zcy/CN/10.7501/j.issn.0253-2670.2026.12.006

分享至

全文二维码

扫描看全文

引用本文

BibTeX

本文的引用情况

2种不同金属材料的力学参数

科 Family	属数 Number of genus	种数 Number of species	占总种数比例 Percentage of total species (%)	属 Genus	种数 Number of species	占总种数比例 Percentage of total species (%)
鹅膏菌科Amanitaceae	2	11	5.26	鹅膏菌属 Amanita	10	4.78
小菇科 Mycenaceae	2	12	5.74	丝盖伞属 Inocybe	5	2.39
多孔菌科 Polyporaceae	8	14	6.70	蜡蘑属 Laccaria	5	2.39
红菇科 Russulaceae	3	23	11.00	小皮伞属 Marasmius	6	2.87
				小菇属 Mycena	11	5.26
				光柄菇属 Pluteus	5	2.39
				红菇属 Russula	17	8.13
				栓菌属 Trametes	5	2.39

关闭全屏

BibTeX
EndNote
RefWorks
TxT